Compare BMBL & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMBL | CUVL |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Australia |
| Employees | N/A | 16 |
| Industry | Computer Software: Prepackaged Software | Miscellaneous |
| Sector | Technology | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.4M | 374.2M |
| IPO Year | 2021 | N/A |
| Metric | BMBL | CUVL |
|---|---|---|
| Price | $2.83 | $6.25 |
| Analyst Decision | Hold | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $4.46 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 13.3K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $965,658,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.54 | $5.95 |
| 52 Week High | $7.32 | $8.20 |
| Indicator | BMBL | CUVL |
|---|---|---|
| Relative Strength Index (RSI) | 55.25 | 40.60 |
| Support Level | $2.63 | N/A |
| Resistance Level | $2.92 | $6.82 |
| Average True Range (ATR) | 0.12 | 0.42 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 98.55 | 13.33 |
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.